Jie Chen

Address:

4065 S Braeswood Blvd, Houston, TX 77025

VIN:

1HGFA16517L062646

Make:

HONDA

Model:

CIVIC

Year:

2007

US Patent:

7288538, Oct 30, 2007

Filed:

Aug 23, 2004

Appl. No.:

10/924180

Inventors:

Chengde Wu - Pearland TX, US
Daxin Gao - Houston TX, US
Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Robert V. Market - Pearland TX, US

Assignee:

Encysive Pharmaceuticals, Inc. - Houston TX

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

7579340, Aug 25, 2009

Filed:

Aug 22, 2007

Appl. No.:

11/895069

Inventors:

Ronald Biediger - Houston TX, US
Jie Chen - Houston TX, US
Daxin Gao - Houston TX, US
Robert Market - Pearlman TX, US
Chengde Wu - Pearland TX, US

Assignee:

Pfizer Inc - New York NY

International Classification:

A61K 31/5375
A61K 31/4523
A61K 31/4025
A61K 31/381
C07D 413/10
C07D 409/10

US Classification:

51421019, 5142315, 514326, 514422, 514444, 544146, 546213, 548527, 548950, 549 59, 549 60

Abstract:

The present invention relates to urotensin II receptor antagonists, CCR-9 antagonists, pharmaceutical compositions containing them and their use.

US Patent:

8178699, May 15, 2012

Filed:

Jul 30, 2008

Appl. No.:

12/183032

Inventors:

Eric C Anderson - Irving TX, US
Ronald J Biediger - Houston TX, US
Jie Chen - Houston TX, US
Brian Dupre - Houston TX, US
Pedro Lory - Antwerp, BE
Robert V. Market - Pearland TX, US
Keith A. Monk - League City TX, US
Michael M. Savage - Pearland TX, US
Reginald Tennyson - Missouri City TX, US
Brandon M. Young - Germantown TN, US

Assignee:

Pfizer Inc. - New York NY

International Classification:

C07D 333/56

US Classification:

549 57

Abstract:

Provided are compounds that are modulators of CCR9 receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, provided are methods for treating or ameliorating diseases associated with modulation of CCR9 receptor activity.

US Patent:

8423454, Apr 16, 2013

Filed:

Jan 6, 2012

Appl. No.:

13/344709

Inventors:

Jie Chen - Chappaqua NY, US
Timothy John Breault - Huntersville NC, US
Fernando Cela Diaz - New York NY, US
William Anthony Nobili - Charlotte NC, US
Sandi Setiawan - Charlottle NC, US
Harsh Singhal - Charlotte NC, US
Agus Sudjianto - Charlotte NC, US
Andrea Renee Turner - Rock Hill SC, US
Bradford Timothy Winkelman - Wilmington DE, US

Assignee:

Bank of America Corporation - Charlotte NC

International Classification:

G06Q 40/00

US Classification:

705 38

Abstract:

Embodiments of the present invention relate to methods and apparatuses for determining leading indicators and/or for modeling one or more time series. For example, in some embodiments, a method is provided that includes: (a) receiving first data indicating the value of a total income amount for a plurality of consumers over a period of time; (b) receiving second data indicating the value of a total debt amount for a plurality of consumers over a period of time; (c) selecting a consumer leverage time series that compares the total income amount to the total debt amount over a period of time; (d) modeling the consumer leverage time series based at least partially on the first and second data; (e) determining, using a processor, the value of the cycle component for a particular time; and (f) outputting an indication of the value of the cycle component for the particular time.

US Patent:

20080188528, Aug 7, 2008

Filed:

Dec 21, 2007

Appl. No.:

12/004956

Inventors:

Ronald J. Biediger - Houston TX, US
Huong M. Bui - Pearland TX, US
Jie Chen - Houston TX, US
Kevin M. Henry - Pearland TX, US
Thomas Thrash - Houston TX, US

International Classification:

A61K 31/4439
C07D 213/02
A61K 31/44
A61K 31/381
A61K 31/34
A61P 25/00
A61P 31/00
A61P 15/08
A61P 9/00
C07D 307/34
C07D 333/02
A61K 31/19

US Classification:

514341, 546298, 514350, 514557, 562400, 5462747, 549 29, 514438, 549487, 514461

Abstract:

Provided are compounds that are modulators of C3a receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, the compounds are pyridones. In certain embodiments, provided are methods for treatment or amelioration of diseases associated with modulation of C3a receptor activity.

US Patent:

20210081673, Mar 18, 2021

Filed:

Sep 9, 2020

Appl. No.:

17/016260

Inventors:

- Princeton NJ, US
Asim KADAV - Jersey City NJ, US
Jie CHEN - Bellevue WA, US

Assignee:

NEC LABORATORIES AMERICA, INC - Princeton NJ

International Classification:

G06K 9/00

Abstract:

Aspects of the present disclosure describe systems, methods, and structures that provide action recognition with high-order interaction with spatio-temporal object tracking. Image and object features are organized into into tracks, which advantageously facilitates many possible learnable embeddings and intra/inter-track interaction(s). Operationally, our systems, method, and structures according to the present disclosure employ an efficient high-order interaction model to learn embeddings and intra/inter object track interaction across the space and time for AR. Each frame is detected by an object detector to locate visual objects. Those objects are linked through time to form object tracks. The object tracks are then organized and combined with the embeddings as the input to our model. The model is trained to generate representative embeddings and discriminative video features through high-order interaction which is formulated as an efficient matrix operation without iterative processing delay.